AUG 11, 2016 11:00 AM PDT

RNA-ISH for Long non-coding RNAs - new game changers in pathology

Speaker
  • Assistant Professor of Pathology Member-Michigan Center for Translational Pathology MLabs Genitourinary Service Line Director Co-Director, University of Michigan Rapid Autopsy Discovery Progr
    BIOGRAPHY

Abstract
DATE: August 11, 2016
TIME: 11:00AM PST, 2:00PM ET, 7:00PM GMT



The central dogma that forms the backbone of molecular biology is that DNA codes for RNA (transcription) which then codes for proteins (translation). However, studies over the last few years demonstrated that just 1.5% of the 3 billion base pairs of DNA constituting the human genome generate the ~20,000 protein coding genes, whereas at least 90% of genome is transcribed into non-coding RNA (ncRNA) that does not result in a protein product.  The rapid characterization of numerous ncRNAs has dramatically altered our understanding of biology.  The discovery of long ncRNAs (lncRNAs, longer than 200 nucleotides) as mediators of various cellular processes as well as various human pathophysiologic processes including cancer has established their role as critical biological entities.  Several lncRNAs have been linked to oncogenesis; for example, HOTAIR in breast and colon cancer, and SChLAP1, PCAT-1 and ANRIL in prostate cancer. SChLAP1 in situ hybridization (RNA-ISH) has been recently demonstrated by our group to be a novel tissue-based biomarker assay for outcome prognostication after radical prostatectomy that carries great clinical promise to help direct risk stratification for patients with prostate cancer. Because RNA-ISH assay is evaluated using a light microscope, it not only allows detection of lncRNA of interest, it provides insight into the localization of the lncRNA as well. Overall, a myriad of lncRNAs are associated with carcinogenesis and RNA-ISH provides a practical tool for clinical application of lncRNA markers of interest in situ.

Learning Objectives
  1. Understand the clinical potential and utility of lncRNAs
  2. Become familiar with RNA-ISH as a clinical translational too

Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
SEP 29, 2022 8:00 AM PDT
SEP 29, 2022 8:00 AM PDT
Date: September 29, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Adeno-associated virus (AAV) is one of the most widely used delivery vehicles in gene therapy. To ensure the safety...
SEP 13, 2022 8:00 AM PDT
SEP 13, 2022 8:00 AM PDT
Date: September 13, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Preparedness against pandemic diseases demands rapid-response vaccine technology and ready-to-use analytical methods...
Loading Comments...
Show Resources